Chorangiosis
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
 
| Chorangiosis | |
|---|---|
| Synonyms | |
| Pronounce | N/A | 
| Specialty | N/A | 
| Symptoms | Increased number of chorionic villi capillaries | 
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Hypoxia, maternal diabetes, high altitude | 
| Risks | |
| Diagnosis | Histopathology | 
| Differential diagnosis | |
| Prevention | |
| Treatment | |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Chorangiosis is a pathological condition affecting the placenta, characterized by an abnormal increase in the number of blood vessels within the chorionic villi, the structures responsible for facilitating nutrient and gas exchange between the mother and fetus. This condition is typically diagnosed through microscopic examination of the placenta after delivery. The diagnosis criteria for chorangiosis include the presence of ten or more capillaries in ten or more villi in ten or more fields at √ó10 magnification. It is considered a sign of chronic hypoxia in the fetus, as the increase in capillary number is thought to be a compensatory mechanism to improve oxygen and nutrient transfer in response to suboptimal conditions.
Etiology
Chorangiosis is associated with several maternal, fetal, and placental conditions that can lead to compromised oxygen delivery to the fetus. These include, but are not limited to, maternal anemia, maternal diabetes, living at high altitudes, and intrauterine growth restriction (IUGR). The exact mechanism leading to chorangiosis is not fully understood, but it is believed to be a response to chronic hypoxic conditions, prompting angiogenesis within the chorionic villi.
Pathophysiology
The pathophysiology of chorangiosis revolves around the body's response to chronic hypoxia. In an attempt to increase the efficiency of oxygen and nutrient transfer from the mother to the fetus, the placenta forms additional blood vessels within the chorionic villi. While this may temporarily alleviate the effects of hypoxia, the presence of chorangiosis can also indicate underlying pathological conditions that may have adverse effects on both the mother and fetus.
Clinical Significance
Chorangiosis itself is typically asymptomatic and is usually diagnosed postpartum through histological examination of the placenta. However, its presence can be indicative of underlying conditions that may require medical attention. It has been associated with an increased risk of neonatal complications, including respiratory distress syndrome and neonatal jaundice. Additionally, chorangiosis may be associated with adverse pregnancy outcomes such as preterm delivery and low birth weight.
Diagnosis
The diagnosis of chorangiosis is made postpartum by examining the placenta under a microscope. The criteria for diagnosis include the presence of an increased number of capillaries in the chorionic villi, specifically ten or more capillaries in ten or more villi in ten or more fields at √ó10 magnification. This examination is typically performed by a pathologist.
Management
Management of chorangiosis involves addressing the underlying conditions that may have led to its development. This can include managing maternal conditions such as diabetes or anemia, monitoring fetal growth and well-being, and making decisions regarding the timing of delivery based on the overall clinical picture. There is no direct treatment for chorangiosis itself, as it is a histopathological diagnosis with no direct clinical interventions.
Summary
Chorangiosis is a placental condition indicative of chronic fetal hypoxia, with potential implications for both maternal and fetal health. While it does not have direct treatments, its identification can prompt closer monitoring and management of underlying conditions that may pose risks to the pregnancy. Understanding the etiology and pathophysiology of chorangiosis is crucial for healthcare providers in optimizing outcomes for affected pregnancies.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
 
 - Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
 
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
 - Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
 
| 
 WikiMD's Wellness Encyclopedia  | 
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates  | 
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian 
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD